Catalyst Wire Dossier Catalyst Wire Dossier

TMC125 (rilpivirine)

rilpivirine · Tibotec Pharmaceuticals Ireland
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TMC125 (rilpivirine), covering 2013-03-07 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216). [Phase 3]

See pricing